Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Sault

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Prenatal Diagnosis|December 24, 2003
Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndromeFrançoise Muller, Sophie Dreux, Alain Lemeur, et al.
Nephrologie & Therapeutique|April 3, 2019
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians]Henri Boulanger, Guillaume Lefèvre, Salima Ahriz Saksi, et al.
Annales De Biologie Clinique|July 14, 2021
Cost-effectiveness threshold of first-trimester Down syndrome maternal serum screening for the use of cell-free DNA as a second-tier screening testMarie Blanquet, Sophie Dreux, Stéphanie Léger, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|April 25, 2026
[Maternal serum markers profiles for Down syndrome : review of comments and actionable recommendations.]Gilles Renom, Magali Pettazzoni, Jean Guibourdenche, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|November 8, 2016
French law: what about a reasoned reimbursement of serum vitamin D assays?Jean-Claude Souberbielle, Claude Laurent Benhamou, Bernard Cortet, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Prenatal Diagnosis|December 24, 2003
Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndromeFrançoise Muller, Sophie Dreux, Alain Lemeur, et al.
Nephrologie & Therapeutique|April 3, 2019
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians]Henri Boulanger, Guillaume Lefèvre, Salima Ahriz Saksi, et al.
Annales De Biologie Clinique|July 14, 2021
Cost-effectiveness threshold of first-trimester Down syndrome maternal serum screening for the use of cell-free DNA as a second-tier screening testMarie Blanquet, Sophie Dreux, Stéphanie Léger, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|April 25, 2026
[Maternal serum markers profiles for Down syndrome : review of comments and actionable recommendations.]Gilles Renom, Magali Pettazzoni, Jean Guibourdenche, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|November 8, 2016
French law: what about a reasoned reimbursement of serum vitamin D assays?Jean-Claude Souberbielle, Claude Laurent Benhamou, Bernard Cortet, et al.
Pageof 2